FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)

View source ↗

Summary

FDA approved a supplemental application for CLOZARIL (clozapine) submitted by HLS Therapeutics (USA), Inc., signaling an update to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia
• Treatment-resistant Schizophrenia

Drugs mentioned

• CLOZARIL (Clozapine)

Snippet

SUPPL AP for CLOZARIL (CLOZAPINE)